{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:31:13Z","timestamp":1780669873006,"version":"3.54.1"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:00:00Z","timestamp":1626134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Reprod. Health"],"abstract":"<jats:p>The WHO guideline on the integration of family planning (FP) and pre-exposure HIV prophylaxis (PrEP) to enhance the health of women and adolescent girls is reflected in the Zambia Consolidated Guidelines for Treatment and Prevention of HIV Infection, 2020. There is however a dearth of data on the integration of PrEP and FP in Zambia. We describe the integration of oral PrEP in FP services using the Evidence for Contraceptive Options and HIV Outcomes (ECHO) study experience at Kamwala District Health Center in Lusaka, Zambia. The provision of oral PrEP at Kamwala started in October 2017, lasting for ~11 months, and utilized the model where initial processes to offer PrEP were on-site followed by off-site referral to laboratory and PrEP provider services. The characteristics of 658 women who enrolled in ECHO at Kamwala are representative of women accessing FP services in Lusaka. About 644 of the enrollees were offered oral PrEP. The proportion of women accepting PrEP was low at 1.08% and the proportion of study visits at which PrEP was requested was also low at 0.57%. Those who accepted PrEP were above 20 years old, married, with at least primary education, sexual behavior, and risk comparable to decliners. The ECHO study experience indicates that the setup and integration of oral PrEP and FP services are feasible in the setting. However, uptake of PrEP was very low. Possible contributory factors were as follows: (1) timing of introduction of PrEP midway in the study, (2) PrEP being a new intervention, (3) challenges of autonomy of young women to include a daily pill into their lives and anticipated challenges to adherence because of fear of adverse events, (4) possible underdetermined risk due to use of an unvalidated risk assessment tool and assessment by health care provider vs. self-assessment, and (5) extra layer of challenges to negotiate due to needing for off-site referrals. Following these findings, we conclude that further research through demonstration projects of integration of oral PrEP and FP may provide solutions to low uptake. This information is critical for scaling up of integration HIV prevention services and sexual and reproductive health (SRH) services.<\/jats:p>","DOI":"10.3389\/frph.2021.684717","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T05:10:36Z","timestamp":1626153036000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Integration of HIV Prevention With Sexual and Reproductive Health Services: Evidence for Contraceptive Options and HIV Outcomes Study Experience of Integrating Oral Pre-exposure HIV Prophylaxis in Family Planning Services in Lusaka, Zambia"],"prefix":"10.3389","volume":"3","author":[{"given":"Margaret Phiri","family":"Kasaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ntazana","family":"Sindano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manze","family":"Chinyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayaba","family":"Mudenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Chilaisha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan T.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Modesta","family":"Chileshe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,13]]},"reference":[{"key":"B1","unstructured":"1422The GAP Report. Joint United Nations Programme on HIV\/AIDS (UNAIDS)2014"},{"key":"B2","unstructured":"AIDSinfo2020"},{"key":"B3","unstructured":"Zambia Demographic and Health Survey 20182020"},{"key":"B4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.contraception.2018.01.007","article-title":"Family planning providers' role in offering PrEP to women","volume":"97","author":"Seidman","year":"2018","journal-title":"Contraception."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e1002885","DOI":"10.1371\/journal.pmed.1002885","article-title":"Integrating preexposure prophylaxis delivery in routine family planning clinics: a feasibility programmatic evaluation in Kenya","volume":"16","author":"Mugwanya","year":"2019","journal-title":"PLoS Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s11904-014-0228-6","article-title":"Combination HIV prevention interventions: the potential of integrated behavioral and biomedical approaches","volume":"11","author":"Brown","year":"2014","journal-title":"Curr HIV\/AIDS Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s40265-019-01143-8","article-title":"Pre-exposure prophylaxis for HIV prevention in women: current status and future directions","volume":"79","author":"Hodges-Mameletzis","year":"2019","journal-title":"Drugs."},{"key":"B8","volume-title":"WHO Implementation Tool for Pre-exposure Prophylaxis (PrEP) of HIV Infection. Module 8: Site Planning","year":"2017"},{"key":"B9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV prevention in heterosexual men and women","volume":"367","author":"Baeten","year":"2012","journal-title":"N Engl J Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1402269","article-title":"Tenofovir-based preexposure prophylaxis for HIV infection among African women","volume":"372","author":"Marrazzo","year":"2015","journal-title":"N Engl J Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJMoa1110711","article-title":"Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana","volume":"367","author":"Thigpen","year":"2012","journal-title":"N Engl J Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1202614","article-title":"Preexposure prophylaxis for HIV infection among African women","volume":"367","author":"Van Damme","year":"2012","journal-title":"N Engl J Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"591","DOI":"10.7326\/0003-4819-146-8-200704170-00010","article-title":"Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1","volume":"146","author":"Cohen","year":"2007","journal-title":"Ann Intern Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/S0140-6736(11)61136-7","article-title":"Antiretroviral prophylaxis: a defining moment in HIV control","volume":"378","author":"Karim","year":"2011","journal-title":"Lancet."},{"key":"B16","volume-title":"Contraceptive Eligibility for Women at High Risk of HIV. Guidance Statement :Recommendations on Contraceptive Methods used by Women at High Risk of HIV","year":"2019"},{"key":"B17","volume-title":"Zambia's National HIV and AIDS Strategic Framework 2017-2021","year":"2017"},{"key":"B18","volume-title":"Zambia-Consolidated-Guidelines-for-Treatment-and-Prevention-of-HIV-Infection-2020","year":"2020"},{"key":"B19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0140-6736(19)31288-7","article-title":"HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial","volume":"394","author":"Consortium","year":"2019","journal-title":"Lancet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1007\/s10461-020-03072-0","article-title":"Exploring the use of oral pre-exposure prophylaxis (PrEP) among women from Durban, South Africa as part of the HIV prevention package in a clinical trial","volume":"25","author":"Beesham","year":"2021","journal-title":"AIDS Behav"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e25381","DOI":"10.1002\/jia2.25381","article-title":"Integrated provision of topical pre-exposure prophylaxis in routine family planning services in South Africa: a non-inferiority randomized controlled trial","volume":"22","author":"Mansoor","year":"2019","journal-title":"J Int AIDS Soc."},{"key":"B22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/COH.0000000000000221","article-title":"Planning for HIV preexposure prophylaxis introduction: lessons learned from contraception","volume":"11","author":"Delany-Moretlwe","year":"2016","journal-title":"Curr Opin HIV AIDS."},{"key":"B23","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/QAI.0000000000002481","article-title":"Model-based predictions of HIV incidence among African women using HIV risk behaviors and community-level data on male HIV prevalence and viral suppression","volume":"85","author":"Moore","year":"2020","journal-title":"J Acquir Immune Defic Synd"},{"key":"B24","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1186\/s12889-021-10766-0","article-title":"PrEP reminds me that I am the one to take responsibility of my life: a qualitative study exploring experiences of and attitudes towards pre-exposure prophylaxis use by women in Eswatini","volume":"21","author":"Bjertrup","year":"2021","journal-title":"BMC Public Health."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s10461-015-1081-3","article-title":"Pre-exposure prophylaxis adherence measured by plasma drug level in MTN-001: comparison between vaginal gel and oral tablets in two geographic regions","volume":"20","author":"Minnis","year":"2016","journal-title":"AIDS Behav."},{"key":"B26","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1097\/QAI.0000000000000974","article-title":"An empiric HIV risk scoring tool to predict HIV-1 acquisition in African women","volume":"72","author":"Balkus","year":"2016","journal-title":"JAIDS."},{"key":"B27","volume-title":"Guideline on When to Start Antiretroviral Therapy and on Pre-exposure Prophylaxis for HIV","year":"2015"}],"container-title":["Frontiers in Reproductive Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2021.684717\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T05:10:45Z","timestamp":1626153045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2021.684717\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,13]]},"references-count":27,"alternative-id":["10.3389\/frph.2021.684717"],"URL":"https:\/\/doi.org\/10.3389\/frph.2021.684717","relation":{},"ISSN":["2673-3153"],"issn-type":[{"value":"2673-3153","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,13]]},"article-number":"684717"}}